Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration

Identification of novel therapeutic targets in obesity and metabolic diseases

31-May-2024 - Evotec SE announced that the Company entered a partnership with Inserm, the French National Institute of Health and Medical Research, Lille University Hospital and Inserm Transfert (the private subsidiary of Inserm) to identify novel therapeutic targets and diagnostic and prognostic markers in ...

Evotec and Owkin enter an A.I.-powered strategic partnership to accelerate therapeutics pipeline in oncology and I&I

04-Jan-2024 - Evotec SE and Owkin, a French-American techbio startup announced an A.I.-powered integrated multi-target collaboration in oncology, immunology and inflammation (“I&I”). The collaboration brings together highly complementary platforms and expertise to accurately select targets, discover and ...

Evotec and Dow AgroSciences announce collaboration on Cellular Target Profiling

11-Jul-2013 - Evotec AG announced that Evotec and Dow AgroSciences (DOW) have entered into a research collaboration with the objective of leveraging Evotec's chemical proteomics services to support compounds in development at Dow AgroSciences. To this end, Evotec will perform chemical proteomics services ...

Evotec announces second multi-target collaboration with UCB

11-Oct-2011 - Evotec AG announced that it has entered into a second multi year, multi target integrated drug discovery collaboration with UCB in the field of immunology.As part of the collaboration, Evotec will apply their integrated drug discovery expertise and technologies to identify interesting small ...

Evotec and Merck KGaA to collaborate on neurological disease target

24-Nov-2010 - Evotec AG announced that it has signed within the "NEU²-Consortium" framework and partially funded by the Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung - BMBF), an agreement with Merck KGaA, Darmstadt, Germany, to develop pre-clinical candidates for an ...

Evotec Completes Acquisition of DeveloGen

03-Sep-2010 - Following the successful fulfilment of various Closing conditions, the sellers of 99.3% of the shares in DeveloGen AG transferred their shares to Evotec AG. Evotec AG issues 6,750,014 new Evotec Shares from its authorized capital as part consideration for the transaction. Following the ...

Evotec Strengthens Discovery Alliance Business through Acquisition of DeveloGen

16-Jul-2010 - Evotec AG announced the signing of a definitive agreement to acquire DeveloGen, a biopharmaceutical company engaged in the discovery of novel therapeutic approaches for the treatment of metabolic and endocrine disorders. The transaction catalyses Evotec's strategy to become the world leading ...

Evotec Enters into Integrated Drug Discovery Alliance with Genentech

11-May-2010 - Evotec AG announced that it has entered into a multi-year integrated drug discovery alliance with Genentech Inc., a wholly owned member of the Roche Group, to discover novel small molecule therapeutics. Evotec will apply its integrated and innovative drug discovery platform in combination with ...

Evotec and Vifor Pharma Sign Major Cooperation Agreement

Development of preclinical candidate in the field of anaemia

03-Feb-2010 - Evotec AG announced that it has signed an agreement with Vifor Pharma. Evotec will provide and project manage the discovery activities to identify a preclinical candidate for the treatment of anaemia. Due to confidentiality reasons both companies will not reveal further details about the ...

Evotec Achieves Milestone in Medicinal Chemistry Collaboration with Ono Pharmaceutical Co., Ltd.

Evotec receives milestone from Ono for the progression of novel protease inhibitors into lead optimisation

16-Dec-2009 - Evotec AG announced that it has received a milestone payment from Ono Pharmaceutical Co., Ltd. (Ono) from its research collaboration aimed at identifying novel inhibitors for a protease target. The milestone is received for the progression of the medicinal chemistry collaboration into lead ...